首页 | 本学科首页   官方微博 | 高级检索  
     

依达拉奉治疗急性脑梗死疗效观察
引用本文:刘黎蓝. 依达拉奉治疗急性脑梗死疗效观察[J]. 中国医药导报, 2011, 8(10): 82-83
作者姓名:刘黎蓝
作者单位:湛江市第二人民医院药剂科,广东湛江,524003
摘    要:
目的:观察依达拉奉治疗急性脑梗死的临床疗效及安全性。方法:将85例急性脑梗死患者随机分为治疗组(43例)及对照组(42例)。两组均予常规治疗,治疗组在此基础上加用依达拉奉。评价两组的治疗效果及治疗前后临床神经功能缺损程度评分变化。治疗组总有效率高于对照组(P〈O.05),神经功能缺损评分低于对照组(P〈0.05)。结论:依达拉奉治疗急性脑梗死疗效确切,无严重不良反应,可在临床中推广使用。

关 键 词:急性脑梗死  依达拉奉  神经功能缺损程度评分

Clinical observation of Edaravone in treatment of acute cerebral infarction
LIU Lilan. Clinical observation of Edaravone in treatment of acute cerebral infarction[J]. China Medical Herald, 2011, 8(10): 82-83
Authors:LIU Lilan
Affiliation:LIU Lilan Department of Pharmacy,the Second People's Hospital of Zhangjiang City,Zhangjiang 524003,China
Abstract:
Objective:To observe the clinical effect and safety of Edaravone in treatment of patients with acute cerebral infarction(ACI).Methods:85 ACI patients were randomly divided into the treatment group(43 cases) and control group(42 cases).Patients of the two groups were cured with conventional therapy.On this basis,Edaravone was added to the treatment group.The clinical effect and the clinical nerve deficiency scale were evaluated in the two groups before and after treatment.Results:The effective rate in treatm...
Keywords:Acute cerebral infarction  Edaravone  Nerve deficiency scale  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号